Hematology TimesMRD test can predict AML relapseJanuary 22, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesProtein may be therapeutic target for AMLJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesPredicting transformation from MDS to AMLJanuary 14, 2016AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesGenes may be targets for AML therapyJanuary 12, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesStudy reveals germline variants in AML, other cancersDecember 29, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesProtein discovery could have therapeutic implicationsDecember 23, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Hematology NewsChemo quadruples risk for myeloid cancersDecember 18, 2015CMLLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesA potential target for IDH1-mutant cancersDecember 18, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsAcademic hospitals offer better AML survivalDecember 15, 2015AMLPractice ManagementLeukemia, Myelodysplasia, TransplantationBusiness of Medicine
Hematology TimesGenes can stop onset of AML, study suggestsDecember 15, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsMinimal residual disease predicts outcome of allogeneic HCT in acute myeloid leukemiaDecember 14, 2015AML
Hematology TimesRATIFY trial results available after almost 10 years in the makingDecember 11, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsVIDEO: High-intensity conditioning stands ground in MDS, AMLDecember 8, 2015AMLMyelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
Hematology NewsVIDEO: Midostaurin hits mark in FLT3-mutated AMLDecember 7, 2015AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesTeam identifies potential biomarkers for AML therapyDecember 3, 2015Leukemia, Myelodysplasia, TransplantationAML
